Author(s):
Hany A. Al-hussaniy, Dhuha Mahdi Noori, Faizul Azam, Zahraa Salam Al-Tameemi, Fatima Akeel Naji, Mazin Mohammed Jwaid, Ali Hikmat Alburghaif
Email(s):
Hany_akeel2000@yahoo.com
DOI:
10.52711/0974-360X.2025.00089 
Address:
Hany A. Al-hussaniy1*, Dhuha Mahdi Noori2, Faizul Azam3, Zahraa Salam Al-Tameemi1, Fatima Akeel Naji1, Mazin Mohammed Jwaid4, Ali Hikmat Alburghaif5
1Dr Hany Akeel Institute, Iraqi Medical Research Center, Baghdad, Iraq.
2Department of Pharmaceutical Chemistry, College of Pharmacy, Al-Zahraa University for Women, Karbala, Iraq.
3Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah, 51452, Saudi Arabia.
4Department of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad, Baghdad, Iraq.
5Department of pharmacology, Ibn Sina University for Medical and Pharmaceutical Sciences, Baghdad, Iraq.
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2025
ABSTRACT:
Background: beta-blockers have been used several times to treat various cardiovascular and non-cardiovascular diseases. However, there is some time limited by side effects and contraindications. Recently, several studies suggest that several medications (not belonging to beta-blocker classes) may have a beta-blocking impact or bind to beta receptors. Aim: This is a systemic review conducted to find out the non-Beta blocker medications that have a degree of beta-blocking effect. Materials and Methods: This systemic review was conducted by using search engines; we found about 1090 articles related to our aim using search Keywords such as "beta blocker", "bronchospasm", and "increase peripheral vascular resistance" on several search engines, including PubMed, Google Scholar, Base search, in articles published from 2010 to march 2023. Result: the review focused on the adverse effects of several medications on several classes and identified several non-beta blocker medications that may have Beta-blocker effects as side effects such as bradycardia, bronchospasm, Raynaud syndromes, and increased blood resistance. Conclusion: Understanding the beta-blocking side effects of several not beta blocker medications may open the field of understanding the mechanisms of action of this medication or this medication may really bond to beta receptors and produce these effects.
Cite this article:
Hany A. Al-hussaniy, Dhuha Mahdi Noori, Faizul Azam, Zahraa Salam Al-Tameemi, Fatima Akeel Naji, Mazin Mohammed Jwaid, Ali Hikmat Alburghaif. Non-Beta-Blocker Medications with Beta-Blocker Like Properties: A Systematic Review of Side Effects.. Research Journal of Pharmacy and Technology.2025;18(2):599-5. doi: 10.52711/0974-360X.2025.00089
Cite(Electronic):
Hany A. Al-hussaniy, Dhuha Mahdi Noori, Faizul Azam, Zahraa Salam Al-Tameemi, Fatima Akeel Naji, Mazin Mohammed Jwaid, Ali Hikmat Alburghaif. Non-Beta-Blocker Medications with Beta-Blocker Like Properties: A Systematic Review of Side Effects.. Research Journal of Pharmacy and Technology.2025;18(2):599-5. doi: 10.52711/0974-360X.2025.00089 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-2-21
REFERENCES:
1. Beta blockers: cardiac jacks of all trades. Uses for beta blockers range from lowering blood pressure to improving heart failure. Harv Heart Lett. 2011; 22(4): 4–5.
2. Kawano S. Beta blockers: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects. Nihon Rinsho. 2007; 65 Suppl 5: 91–7.
3. Bansal SS, Chetan. A contemporary role of beta blockers in myocardial infarction. Cardiol Angiol. 2022; 23–7. DOI:/10.9734/ca/2022/v11i430203
4. Al-Hussaniy HA, Alburghaif AH, AL-Zobaidy MA, Alkuraishy HM, Mostafa-Hedeab G, Azam F, Al-Samydai AM, Al-tameemi ZS, Naji MA. Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs. Journal of Medicine and Life. 2023; 16(4): 49
5. Tanyeri̇ MH, Büyükokuroğlu ME, Tanyeri̇ P, Keleş R, Başarir ŞN, Mutlu O, et al. Chronic Effects of Ziprasidone, Aripiprazole, Blonanserin, Cyamemazine, and Nemonapride on Mice Isolated Detrusor Smooth Muscle. Online türk sağlık bilim derg . 2021; DOI:/10.26453/otjhs.974323
6. Al-Hussaniy HA, Al-Zobaidy MJ. Cytotoxic effect of YH239-EE and its enantiomer on MCF7 cell line. Asian Pacific Journal of Cancer Prevention. 2024; 25(6): 2133.
7. Al-kuraishy AA, Jalil HJ, Mahdi AS, Al-hussaniy H. General anesthesia in patient with Brain Injury. Medical and Pharmaceutical Journal. 2022; 1(1): 25-34.
8. Paroxetine/perphenazine/quetiapine: Extrapyramidal motor side effects and neuroleptic malignant syndrome: case report. React Wkly. 2023; 1938(1): 1051–1051. DOI:/10.1007/s40278-023-31192-z
9. Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, et al. Psychedelics and psychedelic-assisted psychotherapy. Focus (Am Psychiatr Publ). 2021; 19(1): 95–115. DOI:/10.1176/appi.focus.19104
10. Naji MA, Alburghaif AH, Saleh NK, Al-hussaniy HA. Patient expectations regarding consultation with a family doctor: a cross-sectional study. Med Pharm J . 2022; 1(1): 35–40. DOI:/10.55940/medphar20225
11. Komajda M, Isnard R, Cohen-Solal A, Metra M, Pieske B, Ponikowski P, et al. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial: Ivabradine in HFpEF. Eur J Heart Fail . 2017; 19(11): 1495–503. DOI:/10.1002/ejhf.876
12. Liao C-T, Huang J-L, Liang H-W, Chung F-P, Lee Y-H, Lin P-L, et al. The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients. ESC Heart Fail . 2021; 8(5):4199–210. DOI:/10.1002/ehf2.13536
13. Longueira J, Thomas C, Pyles E, Subedi B. 130: Calcium channel blockers versus beta blockers for acute rate control in heart failure patients. Crit Care Med. 2023; 51(1): 48–48. DOI:/10.1097/01.ccm.0000906256.17947.74
14. Woodman R, Student J, Miller C, Lockette W. Ivabradine-induced bradycardia is accompanied by reduced stress-related anxiety. Am J Hypertens . 2023; DOI:/10.1093/ajh/hpad019
15. Ivabradine/tamsulosin: Syncope, second degree atrioventricular block and orthostatic Hypotension: case report. React Wkly . 2021; 1849(1): 258–258. DOI:/10.1007/s40278-021-93642-0
16. Mancano MA. ISMP adverse drug reactions: Pregabalin-induced stuttering nitroglycerine-induced bradycardia progressing to asystole minocycline-induced DRESS leading to liver transplantation and type 1 diabetes increased risk of vertebral fractures in women receiving thiazide or loop diuretics gambling disorder and impulse control disorder with aripiprazole. Hosp Pharm . 2017; 52(4): 253–7. DOI:/10.1310/hpj5204-253
17. Uemura K, Kawada T, Nishikawa T, Zheng C, Meihua L, Sigimachi M. P4605Landiolol, a beta-blocker, optimizes cardiac energetics and peripheral microhemodynamics better than ivabradine while reducing heart rate at hemodynamic resuscitation of experimental septic shock. Eur Heart J. 2019; 40(Supplement_1). DOI:/10.1093/eurheartj/ehz745.0988
18. Guimarães GV, d’Avila VM, Camargo PR, Moreira LFP, Lanz JR, Bocchi EA. Prognostic value of cardiopulmonary exercise testing in children with heart failure secondary to idiopathic dilated cardiomyopathy in a non-beta-blocker therapy setting. Eur J Heart Fail. 2008; 10(6): 560–5. DOI:/10.1016/j.ejheart.2008.04.009
19. Eapen JJ, Bang J. Management of Bronchospasm. In: Abd-Elsayed A, editor. Advanced Anesthesia Review. Oxford University Press New York; 2023. p. 281-C111.S8.
20. Kofler T, Hess S, Moccetti F, Pepine CJ, Attinger A, Wolfrum M, et al. Efficacy of ranolazine for treatment of coronary microvascular dysfunction-a systematic review and meta-analysis of randomized trials. CJC open. 2021; 3: 101–8.
21. Khitri AR, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, et al. Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter. J Cardiovasc Electrophysiol. 2012; 23(5): 462–72. DOI:/10.1111/j.1540-8167.2011.02234.x
22. Lecrubier Y, Judge R, The Collaborative Paroxetine Panic Study Investigators. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Psychiatr Scand. 1997; 95(2): 153–60. DOI:/10.1111/j.1600-0447.1997.tb00389.x
23. Ofiaeli OC, Ndukwu CI, Ugwu NO, Nnamani KO, Ebenebe JC, Egbuonu I. Exercise Induced Bronchospasm and associated factors in primary school children: a cross-sectional study. BMC Pediatr. 2023; 23(1): 153. DOI:/10.1186/s12887-023-03963-w
24. Maciejewska M, Sikora M, Maciejewski C, Alda-Malicka R, Czuwara J, Rudnicka L. Raynaud's phenomenon with focus on systemic sclerosis. J Clin Med. 2022; 11(9). DOI:/10.3390/jcm11092490
25. Beshna EA, Alahrish RA. Pharmacists' knowledge and attitudes toward Pharmacogenomics in Zawia, Libya. Medical and Pharmaceutical Journal. 2023; 2(3): 158-66.
26. Gonçalves CM, Cordeiro LR, de Andrade CAF, de Carvalho JF. Lymphocytic interstitial pneumonia associated with Sjögren syndrome: Case-based review. Curr Rheumatol Rev. 2023; 19(1): 1–6. DOI:/10.2174/1573397118666220817091520
27. Koracevic G, Micic S, Stojanovic M, Radovanovic RV, Pavlovic M, Kostic T, et al. Beta Blockers can Mask not only Hypoglycemia but also Hypotension. Curr Pharm Des. 2022; 28(20): 1660–8. DOI:/10.2174/1381612828666220421135523
28. Babu A, John A. Beta blockers in HF, reduced EF And Increased HR. J Drug Deliv Ther. 2022; 12(6): 224–6. DOI:/10.22270/jddt.v12i6.5730
29. Drvota V, Haggblad J, Blange I, Magnusson Y, Sylvén S. The effect of amiodarone on the beta-adrenergic receptor is due to a downregulation of receptor protein and not to a receptor-ligand interaction. Biochem Biophys Res Commun. 1999; 255(2): 515–20. DOI:/10.1006/bbrc.1998.0138
30. Almeida OP, Hankey GJ, Ford A, Etherton-Beer C, Flicker L, Hackett M, et al. Depression outcomes among patients treated with fluoxetine for Stroke Recovery: The Affinity randomized clinical trial: The Affinity randomized clinical trial. JAMA Neurol. 2021; 78(9): 1072–9. DOI:/10.1001/ jamaneurol.2021.2418
31. Ahmed, M.S., Reyadh, A.R., Shareef, B.Q., Ali, A.R.H., Hany, A.H.A. and Meena, A.N.,. Increasing Prevalence of Congenital Hypothyroidism in children with Down Syndrome who have a family history of Thyroid disease. Research Journal of Pharmacy and Technology. 2023; 16(3): 1327-1332.
32. Edenta C, Development and Evaluation of Fast Dissolving Thin Films of Aripiprazole. Development and evaluation of fast dissolving thin films of aripiprazole. Univers J Pharm Res. 2017; 2(5): 23–7. DOI:/10.22270/ujpr.v2i5.r5
33. Prieto-Garcia JM, Graham L, Alkhabbaz O, Mazzari ALDA. Potential pharmacokinetic interactions of common cardiovascular drugs and selected European and Latin American herbal medicines: A scoping review. Plants. 2023; 12(3). DOI:/10.3390/ plants12030623
34. Al-Hussaniy HA, Al-Zobaidy MJ. Effects of Mdm2 Inhibitors on Cellular Viability of Breast Cancer Cell Lines HP100, MCF7. Bratislava Medical Journal/Bratislavské Lekárske Listy. 2024; 125(10): 27–634.
35. Hubers SA, Brown NJ. Combined angiotensin receptor antagonism and neprilysin inhibition. Circulation. 2016; 133(11): 1115–24. DOI:/10.1161/circulationaha.115.018622
36. Simko F, Baka T. Ivabradine and blood pressure reduction: Underlying pleiotropic mechanisms and clinical implications. Front Cardiovasc Med. 2021; 8. DOI:/10.3389/fcvm.2021.607998
37. Ware WA, Bonagura JD, Scansen BA. Antiarrhythmic Therapies. In: Cardiovascular Disease in Companion Animals. Boca Raton: CRC Press; 2021. p. 373–96.
38. Tamunobelema DMS, Uruaka CI. General Anaesthetic Agents and Their Implication on the Cardiovascular System: A Systematic Review. Saudi J Med Pharm Sci. 2023; 9(3): 171–84.
39. Thomas D, Christ T, Fabritz L, Goette A, Hammwöhner M, Heijman J, et al. German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management. Clin Res Cardiol. 2019; 108(6): 577–99. DOI:/10.1007/s00392-018-1377-1
40. Dimoula A, Fotellis D, Aivalioti E, Delialis D, Polissidis A, Patras R, et al. Off-target effects of antidepressants on vascular function and structure. Biomedicines. 2021; 10(1): 56. DOI:/10.3390/ biomedicines10010056
41. Agbaraolorunpo FM, Sofola OA, Anigbogu CN, Azinge EC. Angiotensin receptor blockade with Losartan attenuates pressor response to handgrip contraction and enhances natriuresis in salt loaded hypertensive subjects: a quasi-experimental study among Nigerian adults. Pan Afr Med J. 2019; 34. DOI:/10.11604/ pamj.2019.34.188.18317
42. Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic drugs: From receptor-binding profiles to metabolic side effects. Curr Neuropharmacol. 2018; 16(8): 1210–23. DOI:/10.2174/ 1570159x15666170630163616
43. Kawabata M, Yokoyama Y, Sasaki T, Tao S, Ihara K, Shirai Y, et al. Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers. Clin Pharmacol . 2015; 29. DOI:/10.2147/cpaa.s77021
44. Giovannitti JA Jr, Thoms SM, Crawford JJ. Alpha-2 adrenergic receptor agonists: A review of current clinical applications. Anesth Prog. 2015; 62(1): 31–8. DOI:/10.2344/0003-3006-62.1.31
45. Salim Mahmood A, Ammoo AM, Ali MH, Hameed TM, Al-Hussaniy HA, Aljumaili AA, Al-Fallooji MH, Kadhim AH. Antiepileptic Effect of Neuroaid® on Strychnine-Induced Convulsions in Mice. Pharmaceuticals. 2022; 15(12): 1468.
46. Devaki R, Shankar Rao S, Nadgir SM. The effect of lithium on the adrenoceptor-mediated second messenger system in the rat brain. J Psychiatry Neurosci. 2006; 31(4): 246–52.
47. Mohamed Saleem TS. Dronedarone in the management of atrial fibrillation. Open Access Emerg Med. 2010; 17. DOI:/10.2147/ oaem.s8988
48. Awad M, Al-Hussaniy HA, Alburghaif AH, Tawfeeq KT. The role of COVID-19 in myopathy: incidence, causes, treatment, and prevention. Journal of Medicine and Life. 2022; Dec; 15(12): 1458.
49. Grigorean VT, Sandu AM, Popescu M, Iacobini MA, Stoian R, Neascu C, et al. Cardiac dysfunctions following spinal cord injury. J Med Life. 2009; 2(2): 133–45.
50. Gasmi M, Hooker RW, Maaouia GB, Chikhad AB. The effects of intermittent fasting on markers of health: A narrative review. Medical and Pharmaceutical Journal. 2023; Jul 30; 2(2): 121-33.
51. Abdulhamza HM, Farhan MS, Hassan SS, Al-Hussainy HA, Oriabi AI. In silico identification of antiviral compounds for the treatment of chikungunya virus infection: qsar modelling and md simulation analysis. Medicine in Novel Technology and Devices. 2024; 22: 100304.
52. Al-Hussaniy HA, Hassan AF, Oraibi AI, Al-Juhaishi AM, Naji FA, Al-Tameemi ZS. Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq. Journal of Pharmacy and Bioallied Sciences. 2023; 15(3): 101-6.
53. Al-Hussaniy HA, Al-kuraishy AA, Jalil HJ. Evaluation of the efficacy of adrenergic neurons inhibition through various surgical and therapeutic regimens on controlling blood pressure and circadian rhythm in patients with uncontrolled hypertension. Journal of Clinical Trials and Experimental Investigations. 2022; 1(3): 106-13.
54. Al_hussaniy HA, Alkhafaje Z, Altamimi ZS, Oraibi AI, Abdalhassan AH, Abdulhamza HM, AL-Zobaidy MJ. Memantine and its role in parkinsonism, seizure, depression, migraine headache, and Alzheimer’s disease. Pharmacia. 2023; 70(2): 291-7.
55. Kalantri M. R. , Aher A. N. Review on herbal drugs used in treatment for Asthma. Res. J. Pharmacognosy and Phytochem. 2018; 10(1): 63-67.
56. Vipul Shah, Vrunda Shah, DD Santani. Asthma and Plants used for Asthma-An Overview. Research J. Pharmacology and Pharmacodynamics. 2012; 4(5): 328-338.
57. Al-Hussaniy HA, Аlmajidi YQ, Oraibi AI, Alkarawi AН. Nanoemulsions as medicinal components in insoluble medicines. Pharmacia. 2023; 70(3): 537-47.
58. Al-hussaniy HA, Al-Shammari AH, Sameer HN, Oraibi AI. The relationship between statin therapy and adipocytokine/ inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study. Pharmacia. 2023; 70(3): 581-5.
59. Piyushkumar M. Pargi, Bhargav M. Purohit, Lla N. Hadiyel, Tathagata Roy, Debraj Mukhopadhyay, Somsubhra Ghosh, Susanta Paul. Metoprolol Induced oral Lichen planus in An adult Female Patient – A Case Report. Research J. Pharm. and Tech 2020; 13(9): 4274-4276.
60. Al-Hussaniy HA, Al-Samydai A, Hajleh MN, Mayyas A, Oraibi AI. Selection and Progress of drugs for treating Dementia. Research Journal of Pharmacy and Technology. 2024; 17(4): 1674-8.